Depression
The PHQ-9 for Seniors: How Depression Is Measured, and Improved
By Total Life · July 7, 2026
The PHQ-9 is a nine-question depression screening tool scored 0-27, used across medicine to detect depression and track whether treatment is working. Scores of 5-9 suggest mild depression, 10-14 moderate, 15-19 moderately severe, and 20+ severe. For seniors, it matters doubly: it catches depression that hides behind fatigue and aches, and it turns therapy progress into numbers you can see. Medicare covers depression screening free once a year.
Check My Medicare Coverage
What the PHQ-9 asks
If a doctor or therapist has handed you (or a parent) this short questionnaire, here's what it is, what the score means, and why good practices use it at every stage of care.
Nine questions about the past two weeks, how often you've been bothered by things like little interest or pleasure in activities, feeling down or hopeless, sleep trouble, low energy, appetite changes, feeling bad about yourself, trouble concentrating, moving or speaking slowly (or restlessness), and thoughts of being better off dead. Each answer scores 0 (not at all) to 3 (nearly every day). Total: 0-27. It takes about three minutes and can be done on paper, on screen, or read aloud by phone.
What the scores mean
| PHQ-9 score | Interpretation |
|---|---|
| 0-4 | Minimal or no depression |
| 5-9 | Mild depression |
| 10-14 | Moderate depression |
| 15-19 | Moderately severe depression |
| 20-27 | Severe depression |
Two more numbers worth knowing: a drop of 5 or more points is generally considered clinically meaningful improvement, and a score below 5 with sustained gains indicates remission. A score of 10 or higher typically prompts a fuller clinical evaluation, a screening result is a signal, not a diagnosis by itself.
Most Total Life patients pay $0 out of pocket.
Covered by Medicare. Licensed therapists who specialize in adults 65+. Matched within 48 hours.
Get StartedWhy the PHQ-9 matters more after 65
Late-life depression is a master of disguise, presenting as fatigue, unexplained pain, insomnia, irritability, and memory complaints rather than sadness, which is why most cases go undiagnosed (PMC; StatPearls). A structured tool doesn't care what you call your symptoms; it captures the pattern anyway. That's part of why so much late-life depression goes untreated, about 78% in one national cohort (PMC), and why routine screening is the fix: Medicare covers one depression screening per year at no cost, plus a mood review in every Annual Wellness Visit.
From screening to measurement-based care
The PHQ-9's real power isn't the first score, it's the trend. In measurement-based care, the questionnaire is repeated at regular intervals through therapy, and treatment decisions follow the data: improving on pace, stay the course; plateaued, change the approach, adjust intensity, or coordinate with your physician. Research links this data-driven model to better depression outcomes than usual care, because non-response gets caught early instead of drifting for months.
That's how Total Life practices: PHQ-9 (and GAD-7 for anxiety) at intake and on a set cadence throughout therapy, done verbally for phone-based members, with your trajectory reviewed together. Therapy itself is Medicare-covered psychotherapy delivered to your home by video or phone, typically $0 with supplemental coverage (Telehealth.HHS.gov). See your starting point at totallife.com.
Common questions
Frequently asked questions
What is a normal PHQ-9 score? +
What PHQ-9 score indicates depression? +
Is the PHQ-9 accurate for older adults? +
Can the PHQ-9 be done by phone? +
How often should the PHQ-9 be repeated during treatment? +
Is depression screening free with Medicare? +
This article is educational and not a substitute for professional care. If you or someone you love is thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), it's free, confidential, and available 24/7. This is a sensitive topic; if you're personally struggling, help is available and treatment works.
Sources: NIH / NCBI | NIH / NCBI | HHS Telehealth
